文献速递肿瘤 PET/CT

SARS-CoV-2感染后高级别非霍奇金淋巴瘤自发缓解:一例病例报告

Spontaneous Remission of High-Grade Non-Hodgkin Lymphoma After SARS-CoV-2 Infection: A Case Report.
PubMed 文献 · Clin Nucl Med · 2023-11-29

本文报告一例新诊断高级别非霍奇金淋巴瘤且未接受任何肿瘤特异性治疗的患者,在感染SARS-CoV-2后,2-[18F]FDG PET/CT观察到完全代谢缓解。尽管癌症患者感染SARS-CoV-2后不良结局风险较高,但病毒在某些情况下可能表现抗肿瘤效应,此前已有SARS-CoV-2的个案报告。

要点

  • 癌症患者感染SARS-CoV-2后不良结局风险较高。
  • 病毒在某些情况下可能表现抗肿瘤效应,SARS-CoV-2已有个案报告。
  • 本例高级别非霍奇金淋巴瘤未接受肿瘤特异性治疗,感染SARS-CoV-2后PET/CT示完全代谢缓解。

核心结论

  • 一例新诊断高级别非霍奇金淋巴瘤且未接受肿瘤特异性治疗的患者,在感染SARS-CoV-2后2-[18F]FDG PET/CT观察到完全代谢缓解。

研究设计与样本

  • 病例报告,报告一例新诊断高级别非霍奇金淋巴瘤且未接受任何肿瘤特异性治疗的患者。

主要发现

  • 该患者感染SARS-CoV-2后,2-[18F]FDG PET/CT观察到完全代谢缓解。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite extensive research into COVID-19 since its emergence in late 2019, there is still much not fully understood about its long-term effects. When infected with SARS-CoV-2, cancer patients have been reported to be at higher risk for unfavorable outcomes. Nevertheless, evidence suggests that viruses may exhibit an antitumor effect in some cases, which has recently been anecdotally reported with SARS-CoV-2. We present the case of a patient with a recent high-grade non-Hodgkin lymphoma diagnosis and without any cancer-specific therapy, in whom a complete metabolic response on 2-[ 18 F]FDG PET/CT was observed after COVID-19.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Teixeira Ferreira R, Cardoso Ferreira I, Carmona S, et al. Spontaneous Remission of High-Grade Non-Hodgkin Lymphoma After SARS-CoV-2 Infection: A Case Report. Clin Nucl Med. 2023. PMID: 38048523. doi:10.1097/RLU.0000000000004973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。